Peter Wehrly

Peter Wehrly is an accomplished executive with extensive experience in the medical device and biologics industries. Currently serving as President-U.S. at Premia Spine since January 2023, Wehrly previously held the role of Chief Executive Officer at Vivex Biologics from July 2019 to January 2022. Other notable positions include Executive Chairman of the Board at Synaptive Medical and President & CEO of PQ Bypass. Wehrly's tenure at Covidien spanned several key leadership roles, including Group President for Developed Markets and Respiratory & Monitoring Solutions. Additional experience includes leadership positions at Medingo Ltd., Medtronic Sofamor Danek, and DePuy Orthopaedics. Wehrly holds a Bachelor of Science degree in Management from Ball State University's Miller College of Business, obtained in 1981.